Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 30, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0
|
—
|
—
|
—
|
0
|
Jan 26
| ||||||||
Resmed Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Resmed Inc
| -1.38K |
$148.94 | -$204,825.12 | -9.03% | 13.85K |
Nov 20
| |||||||
Resmed Inc
| -1.70K |
$143.60 | -$244,734.90 | -10.07% | 15.22K |
Nov 13
| |||||||
Resmed Inc
| -1.50K |
$181.01 | -$271,515.00 | -0.60% | 250.53K |
Aug 15
| |||||||
Resmed Inc
| -1.50K |
$222.22 | -$333,330.00 | -0.59% | 252.03K |
Jul 17
| |||||||
Resmed Inc
| -1.50K |
$216.27 | -$324,405.00 | -0.59% | 253.53K |
Jun 15
| |||||||
Resmed Inc
| -1.50K |
$232.85 | -$349,275.00 | -0.58% | 255.03K |
May 15
| |||||||
Resmed Inc
| -1.50K |
$224.65 | -$336,975.00 | -0.58% | 256.53K |
Apr 17
| |||||||
Resmed Inc
| -3.42K |
$206.14 | -$309,210.00 | -1.31% | 258.03K |
Mar 15
|
Scheduled
| ||||||
Globus Medical Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 26
| |||||||
Resmed Inc
| -1.50K |
$213.50 | -$320,250.00 | -0.57% | 261.44K |
Feb 15
|
Scheduled
| ||||||
Resmed Inc
| -1.50K |
$220.43 | -$330,645.00 | -0.66% | 226.21K |
Jan 17
|
Scheduled
| ||||||
Resmed Inc
| 13.37K |
$224.40 | -$4,358,970.00 | +33.27% | 53.56K |
Nov 23
| |||||||
Resmed Inc
|
0
|
—
|
—
|
—
|
0
|
Nov 16
| |||||||
Resmed Inc
| 6.75K |
$140.16 | -$1,454,755.77 | +20.20% | 40.19K |
Nov 15
|
Scheduled
| ||||||
Resmed Inc
| -1.71K |
$225.18 | -$383,931.90 | -4.85% | 33.43K |
Nov 11
| |||||||
Resmed Inc
| 6.68K |
$136.67 | -$1,392,056.20 | +23.51% | 35.09K |
Oct 14
|
Scheduled
| ||||||
Resmed Inc
| -443.00 |
$145.35 | -$2,945,621.56 | -0.17% | 256.12K |
Sep 15
|
Scheduled
| ||||||
Resmed Inc
| 4.33K |
—
|
—
| +25.11% | 21.56K |
Aug 18
| |||||||
Resmed Inc
|
0
|
$145.76 | -$1,400,400.00 |
—
| 17.18K |
Apr 18
|
Scheduled
| ||||||
Resmed Inc
|
0
|
$148.16 | -$1,438,640.00 |
—
| 17.18K |
Mar 15
|
Scheduled
| ||||||
Resmed Inc
|
0
|
$147.03 | -$1,420,560.00 |
—
| 17.18K |
Feb 15
|
Scheduled
| ||||||
0
|
—
|
—
|
—
|
0
|
Jan 27
| ||||||||
Resmed Inc
|
0
|
$153.02 | -$1,516,480.00 |
—
| 17.18K |
Jan 18
|
Scheduled
| ||||||
Resmed Inc
|
0
|
$157.38 | -$1,586,240.00 |
—
| 17.18K |
Dec 15
|
Scheduled
| ||||||
Resmed Inc
| -791.00 |
—
|
—
| -0.34% | 235K |
Nov 23
| |||||||
Resmed Inc
|
0
|
—
|
—
|
—
|
0
|
Nov 18
| |||||||
Resmed Inc
| 21.29K |
$254.81 | $4,758,831.56 | +100.10% | 42.55K |
Nov 16 - Nov 18
| |||||||
Resmed Inc
| -945.00 |
$164.35 | -$1,953,279.15 | -4.25% | 21.27K |
Nov 11 - Nov 15
|
Scheduled
| ||||||
Resmed Inc
|
0
|
$157.01 | -$1,580,240.00 |
—
| 22.15K |
Oct 15
|
Scheduled
| ||||||
Resmed Inc
|
0
|
$175.04 | -$1,868,720.00 |
—
| 22.15K |
Sep 15
|
Scheduled
| ||||||
Resmed Inc
| 5.38K |
—
|
—
| +32.10% | 22.15K |
Aug 19
| |||||||
Resmed Inc
|
0
|
$166.91 | -$1,738,640.00 |
—
| 16.77K |
Aug 16
|
Scheduled
| ||||||
Resmed Inc
|
0
|
$153.12 | -$1,518,080.00 |
—
| 16.77K |
Jul 15
|
Scheduled
| ||||||
Resmed Inc
|
0
|
$145.17 | -$1,390,880.00 |
—
| 16.77K |
Jun 15
|
Scheduled
| ||||||
Resmed Inc
|
0
|
$126.62 | -$1,094,080.00 |
—
| 16.77K |
May 17
|
Scheduled
| ||||||
Resmed Inc
| -964.00 |
$207.45 | -$199,981.80 | -0.46% | 210.41K |
Apr 15
|
Scheduled
| ||||||
Resmed Inc
| -1.08K |
$185.48 | -$200,503.88 | -0.51% | 211.37K |
Mar 15
|
Scheduled
| ||||||
Resmed Inc
| -1.00K |
$200.46 | -$200,059.08 | -0.47% | 212.45K |
Feb 16
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.